09 Apr 2021 / 17:27 H.
KUALA
LUMPUR: The government will decide on whether Malaysia can continue to use the AstraZeneca Covid-19 vaccine or not at the Covid-19 Vaccine Supply Access Guarantee Special Committee (JKJAV) meeting in two weeks time.
Coordinating Minister for the National Covid-19 Immunisation Programme Khairy Jamaluddin said during the meeting, the government would scrutinise any additional information to be tabled by the panel of experts from the Health Ministry (MOH) before making any decision.
He said the government took note of the report from the European Medicines Agency (EMA) which confirmed for the first time that there was a link between the use of the AstraZeneca vaccine and blood clotting cases.
KUALA LUMPUR (Bernama): The government will decide on whether Malaysia can continue to use the AstraZeneca vaccine or not at the Covid-19 Vaccine Supply Access Guarantee Special Committee (JKJAV) meeting in two weeks time.
Coordinating Minister for the National Covid-19 Immunisation Programme Khairy Jamaluddin said during the meeting, the government would scrutinise any additional information to be tabled by the panel of experts from the Health Ministry before making any decision.
He said the government took note of the report from the European Medicines Agency (EMA) confirming for the first time that there was a link between the use of the AstraZeneca vaccine and blood clotting cases.
Malaysia to review use of AstraZeneca vaccine: Khairy | Daily Express Online dailyexpress.com.my - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyexpress.com.my Daily Mail and Mail on Sunday newspapers.
Thursday, 08 Apr 2021 09:09 PM MYT
Minister of Science, Technology and Innovation Khairy Jamaluddin speaks to reporters during a visit to the vaccination centre at the Indera Mulia Stadium in Ipoh March 16, 2021. Picture by Farhan Najib
Subscribe to our Telegram channel for the latest updates on news you need to know.
KUALA LUMPUR, April 8 Malaysia has decided to join Covax to show global solidarity and to push for vaccine equity for all, said Coordinating Minister for the National Covid-19 Immunisation Programme Khairy Jamaluddin.
Covax is co-led by the Vaccine Alliance (Gavi), the Coalition for Epidemic Preparedness Innovations, and the World Health Organisation. It aims to accelerate the development and production of Covid-19 vaccines, and guarantees fair and equitable access for every country in the world.
Malaysia deliberating over use of AstraZeneca COVID-19 vaccine after EU findings Toggle share menu
Advertisement
Malaysia deliberating over use of AstraZeneca COVID-19 vaccine after EU findings
A medical worker receives a COVID-19 vaccine shot at Kuala Lumpur Hospital on Mar 1, 2021. (Photo: Reuters/Lim Huey Teng)
08 Apr 2021 11:32AM (Updated:
08 Apr 2021 11:40AM) Share this content
Bookmark
KUALA LUMPUR: Malaysia is deliberating whether to proceed with using the AstraZeneca vaccine for its national COVID-19 immunisation programme, following the European Medicines Agency s (EMA) review.
Coordinating Minister for the Immunisation Programme Khairy Jamaluddin on Thursday (Apr 8) said Malaysia has taken note of EMA’s announcement and that the vaccination committee will deliberate on the matter.